The CMU spinout already trained on records from millions of Taiwanese patients, with early testing showing a 50% to 70% success rate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results